Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary InterventionStephen D. Wiviott, Eugene Braunwald, Dietmar Trenk et al.|Circulation|2007Cited by 877
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic EventsDeepak L. Bhatt, Robert A. Harrington, Gregg W. Stone et al.|New England Journal of Medicine|2013Cited by 825
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38Stephen D. Wiviott, Elliott M. Antman, Eugene Braunwald et al.|Circulation|2008Cited by 757
Platelet Inhibition with Cangrelor in Patients Undergoing PCIRobert A. Harrington, Deepak L. Bhatt, Gregg W. Stone et al.|New England Journal of Medicine|2009Cited by 618
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular DiseaseHyun Kuk Kim, Young‐Hoon Jeong, Sidney C. Smith et al.|Thrombosis and Haemostasis|2020Cited by 334